Richard Pitcock, LSPE | |
1417 Randy Rd, Ashland City, TN 37015-2815 | |
(615) 200-2538 | |
(615) 746-5013 |
Full Name | Richard Pitcock |
---|---|
Gender | Male |
Speciality | Psychologist - Clinical Child & Adolescent |
Location | 1417 Randy Rd, Ashland City, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881940237 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC2200X | Psychologist - Clinical Child & Adolescent | PE0000011351 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Richard Pitcock, LSPE 1417 Randy Rd, Ashland City, TN 37015-2815 Ph: (615) 200-2538 | Richard Pitcock, LSPE 1417 Randy Rd, Ashland City, TN 37015-2815 Ph: (615) 200-2538 |
News Archive
Thousands of babies born to mothers who continue to smoke throughout pregnancy despite physician warnings may benefit from new research which suggests that high doses of vitamin C may have the potential to counteract some negative impacts of smoking in unborn babies.
While the placement of stents in newly reopened coronary arteries has been shown to reduce the need for repeat angioplasty procedures, researchers from the Duke Clinical Research Institute have found that stents have no impact on mortality over the long term.
A Medicare meltdown now seems certain, as the U.S. Senate has left early for the weekend, abandoning seniors, military families and baby boomers. The Senate failed to repeal the Medicare physician payment formula that will cause a drastic 21 percent payment cut to physicians who care for Medicare and TRICARE patients.
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Morphotek Inc. announced today the issuance of United States Patent 6,982,169 covering the use of chemical inhibitors to enhance evolution of target host cell genomes by reversibly regulating mismatch repair (MMR) in vivo.
› Verified 2 days ago
Ms. Mary B Beasley, MED. LPC MHSP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1080 Little Marrowbone Rd, Ashland City, TN 37015 Phone: 615-308-5564 |